Brexpiprazole Impurity 24
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Brexpiprazole Impurity 24

● In Stock

Catalogue No.:VE0025315
CAS No.:N/A
Mol. Formula:C13H14ClNO2
Mol. Weight:251.71 g/mol

Additional information on Brexpiprazole Impurity 24

Parent drug

Brexpiprazole

IUPAC Name

2-(4-chlorobutoxy)quinolin-7-ol

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

OC1=CC2=C(C=CC(OCCCCCl)=N2)C=C1

InChI

InChI=1S/C13H14ClNO2/c14-7-1-2-8-17-13-6-4-10-3-5-11(16)9-12(10)15-13/h3-6, 9, 16H, 1-2, 7-8H2

Description

Brexpiprazole Impurity 24 is a characterized process-related and degradation impurity observed during synthesis and stability studies of brexpiprazole. It is routinely identified and confirmed by orthogonal techniques including HPLC with UV detection | LC-MS for molecular ion confirmation | and 1H/13C NMR for structural assignment. The impurity is monitored under validated analytical procedures and controlled to specification limits aligned with ICH Q3A/Q3B guidance. Formation pathways typically involve oxidation or incomplete intermediate conversion | and mitigation strategies include altered reaction quench | improved purification | antioxidant addition and optimized storage conditions. Understanding and controlling Impurity 24 is critical for batch release | stability profiling and regulatory documentation.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url